34,593 Results

TRANSFORM 24-month study results

Transplantation

TRANSFORM 24-month study results

At 24 months, the results of TRANSFORM herald an alternative to the standard of care in de novo kidney transplant recipients.

TRANSFORM 12-month study results

Transplantation

TRANSFORM 12-month study results

The key findings in a nutshell -- the preliminary 12-month results from the TRANSFORM study.

Study design and rationale

Transplantation

Study design and rationale

Begin here with an overview of the design and rationale for the TRANSFORM study.

Winlevi filed with FDA for acne.- Cassiopea

 Added 1 day ago

Cassiopea has submitted a New Drug Application (NDA) to the FDA seeking marketing approval for Winlevi (clascoterone cream 1%) for...

Myovant Sciences completes ptient recruitment for phase III SPIRIT 2 study evaluating relugolix combination therapy in women with endometriosis.

 Added 1 day ago

Myovant Sciences announced that it has completed patient recruitment for its SPIRIT 2 study, the first of two Phase III...

EPOCH 2 Phase III study of HTX 011 in pain control published in Hernia journal.- Heron Therapeutics

 Added 1 day ago

Heron Therapeutics announced that the results from EPOCH 2, a Phase III study of the investigational agent HTX 011 (bupivacaine...

FDA approves Xenleta to treat community-acquired bacterial pneumonia - Nabriva Therapeutics

 Added 1 day ago

Nabriva Therapeutics plc announced that the FDA has approved Nabriva’s new drug applications for the oral and intravenous (IV) formulations...

Phase III DAPA-HF trial of Farxiga positive for treatment of heart failure.-AstraZeneca

 Added 1 day ago

AstraZeneca announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite...

Congress and Symposia

Transplantation

Congress and Symposia

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.

The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation represents a challenge in clinical practice.

Load more